The top Healio cornea-related articles in 2023 included the FDA approval of Vevye for dry eye disease and the efficacy of azithromycin in the treatment of meibomian gland dysfunction.
Check out the year’s top cornea/external disease items below.
Vevye receives FDA approval for dry eye disease
The FDA approved Vevye, a 0.1% cyclosporine ophthalmic solution, for the treatment of signs and symptoms of dry eye disease, according to a press release from Novaliq. Read more.
Azithromycin shows equal efficacy to doxycycline in meibomian gland dysfunction treatment
Azithromycin showed equivalent